Back to ACAD
Well Done, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$8.7M
Q3 2026
Peak value
$9.3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $7.4M |
| Q4 2025 | $8.4M |
| Q1 2026 | $8.2M |
| Q2 2026 | $9.3M |
| Q3 2026 | $8.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $8.7M | 49.4K | — | — |
| Q2 2026 | $9.3M | 52.9K | — | — |
| Q1 2026 | $8.2M | 49.7K | — | — |
| Q4 2025 | $8.4M | 46.9K | — | — |
| Q3 2025 | $7.4M | 42.1K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M